VEGF-B deletion exacerbates motor neuron degeneration [23] and paclitexel-induced sensory neuronopathy [26] in mice, which resembles our earlier finding that VEGF-B deletion worsens outcome from experimental stroke in mice [16], and provides additional support for a neuroprotective role. The gene discussed is VEGFB; the disease is stroke disorder.